Q&A: The CEO of the Alzheimer’s Association on the approval of Aduhelm — and why critics should stop dwelling on the decision
(By Andrew Joseph for STAT) Harry Johns is ready to stop talking about whether or not the Food and Drug
Read moreFDA
‘I’m just winging it’: Faced with confusing data on the new Alzheimer’s drug, doctors scramble to advise their patients
(By Elizabeth Cooney for STAT) Their phones are ringing off the hook and their email inboxes are filling up with
Read moreNew Device Taps Brain Signals To Help Stroke Patients Regain Hand Function
(By Jon Hamilton for NPR) People recovering from a stroke will soon have access to a device that can help
Read moreFDA Weighs Approval of a Lucrative Alzheimer’s Drug but Benefits Are Iffy
(By Harris Meyer for Kaiser Health News) The Food and Drug Administration’s decision next week whether to approve the first
Read moreBiden Administration Signals It’s in No Rush to Allow Canadian Drug Imports
(By Phil Galewitz for Kaiser Health News) The Biden administration said Friday it has no timeline on whether it will
Read moreFDA says it will ban all menthol cigarettes and flavored cigars
(By Nicholas Florko for STAT) WASHINGTON — The Food and Drug Administration announced Thursday that it will ban all menthol
Read moreThe FDA Seeks a New Way to Review Old Drugs Without Causing Prices to Soar
(By Harris Meyer for Kaiser Health News) Chuck Peterson of Omaha, Nebraska, recently experienced a swollen, painful knuckle caused by arthritis.
Read moreFDA fully approves first COVID-19 test
(By Maia Anderson for Becker’s Hospital Review) The FDA has fully approved the first COVID-19 test, the agency said March 17.
Read moreMedical devicemakers warned against use of misleading labels suggesting FDA approval
(By Maia Anderson for Becker’s Hospital Review) The FDA said March 3 that some medical devicemakers have been displaying “FDA registration
Read moreCollaboration between the FDA and industry is essential to foster innovation in Alzheimer’s treatments
(By George Vradenburg and Jeffrey Cummings for STAT) As the Food and Drug Administration moves closer to a decision about whether
Read more